Compound Tirzepatide and Semaglutide: Transparency in FDA Drug Shortage Process & 503b Protection

Perhaps we should simply just prohibit pharmaceutical companies for price gouging Americans, charging us 10 times the price they charge citizens of other countries. If Mounjaro was $150 a month in the US like it is the most other countries, I wouldn’t care about the availability of compound at all.

41 Likes